1CM
SOPH icon

1492 Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

1492 Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
225,751
+17,406
+8% +$84.7K 0.43% 68
2025
Q4 		$973K Buy
+208,345
New +$944K 0.37% 69

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

1492 Capital Management's SOPH Position: Q1 2026 in Review

1492 Capital Management increased its SOPHiA GENETICS (SOPH) stake by 8.4% in Q1 2026, buying an estimated $84.7K and bringing the position to 225,751 shares worth $1.12M. The position accounts for 0.43% of the portfolio, ranked #68.

1492 Capital Management first reported a position in SOPH in Q4 2025 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • 1492 Capital Management held 225,751 shares of SOPHiA GENETICS worth $1.12M as of Q1 2026.
  • 1492 Capital Management bought 17,406 SOPHiA GENETICS shares in Q1 2026, an estimated $84.7K.
  • SOPHiA GENETICS made up 0.43% of 1492 Capital Management's portfolio in Q1 2026, its #68 holding.
  • 1492 Capital Management first reported a position in SOPHiA GENETICS in Q4 2025 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on 1492 Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.